Kaposi's sarcoma-associated herpes virus complement control protein: KCP - complement inhibition and more

Molecular Immunology

Volumn 44, Issue 1-3, 2007, Pages 11-22

  Mark, Linda ^a   Spiller, O Brad ^b   Villoutreix, Bruno O ^c   Blom, Anna M ^a  

^a LUND UNIVERSITY   (Sweden)

^b CARDIFF UNIVERSITY   (United Kingdom)

^c INSERM   (France)

Author keywords

Complement; KCP; KSHV; RCA

Indexed keywords

COMPLEMENT INHIBITOR; HEPARAN; HEPARIN; KAPOSI SARCOMA ASSOCIATED HERPES VIRUS COMPLEMENT CONTROL PROTEIN; MONOCLONAL ANTIBODY; RECOMBINANT PROTEIN; SERINE PROTEINASE; UNCLASSIFIED DRUG; VIRUS PROTEIN;

AMINO TERMINAL SEQUENCE; ARTICLE; BINDING AFFINITY; BINDING SITE; CELL ADHESION; COMPLEMENT INHIBITION; HUMAN; HUMAN HERPESVIRUS 8; HUMORAL IMMUNITY; LEUKOCYTE; MUTAGENESIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN STRUCTURE; VIRION; VIRUS CELL INTERACTION; VIRUS INFECTION;

AMINO ACIDS; COMPLEMENT C3-C5 CONVERTASES; HEPARIN; HEPARITIN SULFATE; HERPESVIRUS 8, HUMAN; HUMANS; IMMUNITY, NATURAL; VIRAL PROTEINS;

HERPESVIRIDAE; HUMAN HERPESVIRUS 8;

EID: 33750487181     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2006.06.018     Document Type: Article

References (103)

1. Adams E.M., Brown M.C., Nunge M., Krych M., and Atkinson J.P. Contribution of the repeating domains of membrane cofactor protein (CD46) of the complement system to ligand binding and cofactor activity. J. Immunol. 147 (1991) 3005-3011
2. Akula S.M., Naranatt P.P., Walia N.S., Wang F.Z., Fegley B., and Chandran B. Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) infection of human fibroblast cells occurs through endocytosis. J. Virol. 77 (2003) 7978-7990
3. Akula S.M., Pramod N.P., Wang F.Z., and Chandran B. Human herpesvirus 8 envelope-associated glycoprotein B interacts with heparan sulfate-like moieties. Virology 284 (2001) 235-249
4. Akula S.M., Pramod N.P., Wang F.Z., and Chandran B. Integrin alpha3beta1 (CD 49c/29) is a cellular receptor for Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) entry into the target cells. Cell 108 (2002) 407-419
5. Akula S.M., Wang F.Z., Vieira J., and Chandran B. Human herpesvirus 8 interaction with target cells involves heparan sulfate. Virology 282 (2001) 245-255
6. Albrecht J.C., and Fleckenstein B. New member of the multigene family of complement control proteins in herpesvirus saimiri. J. Virol. 66 (1992) 3937-3940
7. Albrecht J.C., Nicholas J., Cameron K.R., Newman C., Fleckenstein B., and Honess R.W. Herpesvirus saimiri has a gene specifying a homologue of the cellular membrane glycoprotein CD59. Virology 190 (1992) 527-530
8. Alexander L., Denekamp L., Knapp A., Auerbach M.R., Damania B., and Desrosiers R.C. The primary sequence of rhesus monkey rhadinovirus isolate 26-95: sequence similarities to Kaposi's sarcoma-associated herpesvirus and rhesus monkey rhadinovirus isolate 17577. J. Virol. 74 (2000) 3388-3398
9. Al-Mohanna F., Parhar R., and Kotwal G.J. Vaccinia virus complement control protein is capable of protecting xenoendothelial cells from antibody binding and killing by human complement and cytotoxic cells. Transplantation 71 (2001) 796-801
10. Alsenz J., Lambris J.D., Schulz T.F., and Dierich M.P. Localization of the complement-component-C3b-binding site and the cofactor activity for factor I in the 38 kDa tryptic fragment of factor H. Biochem. J. 224 (1984) 389-398
11. Alsenz J., Schulz T.F., Lambris J.D., Sim R.B., and Dierich M.P. Structural and functional analysis of the complement component factor H with the use of different enzymes and monoclonal antibodies to factor H. Biochem. J. 232 (1985) 841-850
12. Banki Z., Stoiber H., and Dierich M.P. HIV and human complement: inefficient virolysis and effective adherence. Immunol. Lett. 97 (2005) 209-214
13. Bechtel J.T., Winant R.C., and Ganem D. Host and viral proteins in the virion of Kaposi's sarcoma-associated herpesvirus. J. Virol. 79 (2005) 4952-4964
14. Birkmann A., Mahr K., Ensser A., Yaguboglu S., Titgemeyer F., Fleckenstein B., and Neipel F. Cell surface heparan sulfate is a receptor for human herpesvirus 8 and interacts with envelope glycoprotein K8.1. J. Virol. 75 (2001) 11583-11593
15. Blackmore T.K., Hellwage J., Sadlon T.A., Higgs N., Zipfel P.F., Ward H.M., and Gordon D.L. Identification of the second heparin-binding domain in human complement factor H. J. Immunol. 160 (1998) 3342-3348
16. Blackmore T.K., Sadlon T.A., Ward H.M., Lublin D.M., and Gordon D.L. Identification of a heparin binding domain in the seventh short consensus repeat of complement factor H. J. Immunol. 157 (1996) 5422-5427
17. Blom A.M., Kask L., and Dahlback B. Structural requirements for the complement regulatory activities of C4BP. J. Biol. Chem. 276 (2001) 27136-27144
18. Blom A.M., Kask L., and Dahlback B. CCP1-4 of the C4b-binding protein alpha-chain are required for factor I mediated cleavage of complement factor C3b. Mol. Immunol. 39 (2003) 547-556
19. Blom A.M., Webb J., Villoutreix B.O., and Dahlback B. A cluster of positively charged amino acids in the C4BP alpha-chain is crucial for C4b binding and factor I cofactor function. J. Biol. Chem. 274 (1999) 19237-19245
20. Brodbeck W.G., Liu D., Sperry J., Mold C., and Medof M.E. Localization of classical and alternative pathway regulatory activity within the decay-accelerating factor. J. Immunol. 156 (1996) 2528-2533
21. Cai W.H., Gu B., and Person S. Role of glycoprotein B of herpes simplex virus type 1 in viral entry and cell fusion. J. Virol. 62 (1988) 2596-2604
22. Capila I., and Linhardt R.J. Heparin-protein interactions. Angew. Chem. Int. Ed. Engl. 41 (2002) 391-412
23. Cesarman E., Chang Y., Moore P.S., Said J.W., and Knowles D.M. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS- related body-cavity-based lymphomas. N. Engl. J. Med. 332 (1995) 1186-1191
24. Chang Y., Cesarman E., and Pessin M. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 266 (1994) 1865-1869
25. Cohen A., Wolf D.G., Guttman-Yassky E., and Sarid R. Kaposi's sarcoma-associated herpesvirus: clinical, diagnostic, and epidemiological aspects. Crit. Rev. Clin. Lab. Sci. 42 (2005) 101-153
26. Damania B., and Desrosiers R.C. Simian homologues of human herpesvirus 8. Philos. Trans. R. Soc. Lond. B. Biol. Sci. 356 (2001) 535-543
27. De Paoli P. Human herpesvirus 8: an update. Microbes. Infect. 6 (2004) 328-335
28. Desrosiers R.C., Sasseville V.G., Czajak S.C., Zhang X., Mansfield K.G., Kaur A., Johnson R.P., Lackner A.A., and Jung J.U. A herpesvirus of rhesus monkeys related to the human Kaposi's sarcoma-associated herpesvirus. J. Virol. 71 (1997) 9764-9769
29. Engelstad M., Howard S.T., and Smith G.L. A constitutively expressed vaccinia gene encodes a 42-kDa glycoprotein related to complement control factors that forms part of the extracellular virus envelope. Virology 188 (1992) 801-810
30. Fingeroth J.D., Weis J.J., Tedder T.F., Strominger J.L., Biro P.A., and Fearon D.T. Epstein-Barr virus receptor of human B lymphocytes is the C3d receptor CR2. Proc. Natl. Acad. Sci. U.S.A. 81 (1984) 4510-4514
31. Fodor W.L., Rollins S.A., Bianco-Caron S., Rother R.P., Guilmette E.R., Burton W.V., Albrecht J.C., Fleckenstein B., and Squinto S.P. The complement control protein homolog of herpesvirus saimiri regulates serum complement by inhibiting C3 convertase activity. J. Virol. 69 (1995) 3889-3892
32. Ganesh V.K., Smith S.A., Kotwal G.J., and Murthy K.H. Structure of vaccinia complement protein in complex with heparin and potential implications for complement regulation. Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 8924-8929
33. Gordon D.L., Kaufman R.M., Blackmore T.K., Kwong J., and Lublin D.M. Identification of complement regulatory domains in human factor H. J. Immunol. 155 (1995) 348-356
34. Herold B.C., WuDunn D., Soltys N., and Spear P.G. Glycoprotein C of herpes simplex virus type 1 plays a principal role in the adsorption of virus to cells and in infectivity. J. Virol. 65 (1991) 1090-1098
35. Hung S.L., Srinivasan S., Friedman H.M., Eisenberg R.J., and Cohen G.H. Structural basis of C3b binding by glycoprotein C of herpes simplex virus. J. Virol. 66 (1992) 4013-4027
36. Isaacs S.N., Argyropoulos E., Sfyroera G., Mohammad S., and Lambris J.D. Restoration of complement-enhanced neutralization of vaccinia virus virions by novel monoclonal antibodies raised against the vaccinia virus complement control protein. J. Virol. 77 (2003) 8256-8262
37. Isaacs S.N., Kotwal G.J., and Moss B. Vaccinia virus complement-control protein prevents antibody-dependent complement-enhanced neutralization of infectivity and contributes to virulence. Proc. Natl. Acad. Sci. U.S.A. 89 (1992) 628-632
38. Jenner R.G., Alba M.M., Boshoff C., and Kellam P. Kaposi's sarcoma-associated herpesvirus latent and lytic gene expression as revealed by DNA arrays. J. Virol. 75 (2001) 891-902
39. Jokiranta T.S., Cheng Z.Z., Seeberger H., Jozsi M., Heinen S., Noris M., Remuzzi G., Ormsby R., Gordon D.L., Meri S., Hellwage J., and Zipfel P.F. Binding of complement factor H to endothelial cells is mediated by the carboxy-terminal glycosaminoglycan binding site. Am. J. Pathol. 167 (2005) 1173-1181
40. Jokiranta T.S., Hellwage J., Koistinen V., Zipfel P.F., and Meri S. Each of the three binding sites on complement factor H interacts with a distinct site on C3b. J. Biol. Chem. 275 (2000) 27657-27662
41. Judson K.A., Lubinski J.M., Jiang M., Chang Y., Eisenberg R.J., Cohen G.H., and Friedman H.M. Blocking immune evasion as a novel approach for prevention and treatment of herpes simplex virus infection. J. Virol. 77 (2003) 12639-12645
42. Kaleeba J.A., and Berger E.A. Kaposi's sarcoma-associated herpesvirus fusion-entry receptor: cystine transporter xCT. Science 311 (2006) 1921-1924
43. Kapadia S.B., Levine B., Speck S.H., and Virgin H.W.T. Critical role of complement and viral evasion of complement in acute, persistent, and latent gamma-herpesvirus infection. Immunity 17 (2002) 143-155
44. Kapadia S.B., Molina H., van Berkel V., Speck S.H., and Virgin H.W.T. Murine gammaherpesvirus 68 encodes a functional regulator of complement activation. J. Virol. 73 (1999) 7658-7670
45. Kirkitadze M.D., and Barlow P.N. Structure and flexibility of the multiple domain proteins that regulate complement activation. Immunol. Rev. 180 (2001) 146-161
46. Kotwal G.J., Isaacs S.N., McKenzie R., Frank M.M., and Moss B. Inhibition of the complement cascade by the major secretory protein of vaccinia virus. Science 250 (1990) 827-830
47. Kotwal G.J., and Moss B. Vaccinia virus encodes a secretory polypeptide structurally related to complement control proteins. Nature 335 (1988) 176-178
48. Krych M., Clemenza L., Howdeshell D., Hauhart R., Hourcade D., and Atkinson J.P. Analysis of the functional domains of complement receptor type 1 (C3b/C4b receptor; CD35) by substitution mutagenesis. J. Biol. Chem. 269 (1994) 13273-13278
49. Krych-Goldberg M., and Atkinson J.P. Structure-function relationships of complement receptor type 1. Immunol. Rev. 180 (2001) 112-122
50. Krych-Goldberg M., Hauhart R.E., Subramanian V.B., Yurcisin II B.M., Crimmins D.L., Hourcade D.E., and Atkinson J.P. Decay accelerating activity of complement receptor type 1 (CD35). Two active sites are required for dissociating C5 convertases. J. Biol. Chem. 274 (1999) 31160-31168
51. Kuhn S., Skerka C., and Zipfel P.F. Mapping of the complement regulatory domains in the human factor H-like protein 1 and in factor H1. J. Immunol. 155 (1995) 5663-5670
52. Kuhn S., and Zipfel P.F. Mapping of the domains required for decay acceleration activity of the human factor H-like protein 1 and factor H. Eur. J. Immunol. 26 (1996) 2383-2387
53. Kuttner-Kondo L.A., Mitchell L., Hourcade D.E., and Medof M.E. Characterization of the active sites in decay-accelerating factor. J. Immunol. 167 (2001) 2164-2171
54. Liszewski M.K., Leung M.K., Hauhart R., Buller R.M., Bertram P., Wang X., Rosengard A.M., Kotwal G.J., and Atkinson J.P. Structure and regulatory profile of the monkeypox inhibitor of complement: comparison to homologs in vaccinia and variola and evidence for dimer formation. J. Immunol. 176 (2006) 3725-3734
55. Liu J., and Thorp S.C. Cell surface heparan sulfate and its roles in assisting viral infections. Med. Res. Rev. 22 (2002) 1-25
56. Mansfield K.G., Westmoreland S.V., DeBakker C.D., Czajak S., Lackner A.A., and Desrosiers R.C. Experimental infection of rhesus and pig-tailed macaques with macaque rhadinoviruses. J. Virol. 73 (1999) 10320-10328
57. Mark L., Lee W.H., Spiller O.B., Proctor D., Blackbourn D.J., Villoutreix B.O., and Blom A.M. The Kaposi's sarcoma-associated herpesvirus complement control protein mimics human molecular mechanisms for inhibition of the complement system. J. Biol. Chem. 279 (2004) 45093-45101
58. Mark L., Lee W.H., Spiller O.B., Villoutreix B.O., and Blom A.M. The Kaposi's sarcoma-associated herpesvirus complement control protein (KCP) binds to heparin and cell surfaces via positively charged amino acids in CCP1-2. Mol. Immunol. 43 (2006) 1665-1675
59. Mathew E.C., Sanderson C.M., Hollinshead R., and Smith G.L. A mutational analysis of the vaccinia virus B5R protein. J. Gen. Virol. 82 (2001) 1199-1213
60. McKenzie R., Kotwal G.J., Moss B., Hammer C.H., and Frank M.M. Regulation of complement activity by vaccinia virus complement-control protein. J. Infect. Dis. 166 (1992) 1245-1250
61. Miller C.G., Shchelkunov S.N., and Kotwal G.J. The cowpox virus-encoded homolog of the vaccinia virus complement control protein is an inflammation modulatory protein. Virology 229 (1997) 126-133
62. Mossakowska D., Dodd I., Pindar W., and Smith R.A. Structure-activity relationships within the N-terminal short consensus repeats (SCR) of human CR1 (C3b/C4b receptor, CD35): SCR 3 plays a critical role in inhibition of the classical and alternative pathways of complement activation. Eur. J. Immunol. 29 (1999) 1955-1965
63. Mullick J., Bernet J., Panse Y., Hallihosur S., Singh A.K., and Sahu A. Identification of complement regulatory domains in vaccinia virus complement control protein. J. Virol. 79 (2005) 12382-12393
64. Mullick J., Bernet J., Singh A.K., Lambris J.D., and Sahu A. Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) open reading frame 4 protein (kaposica) is a functional homolog of complement control proteins. J. Virol. 77 (2003) 3878-3881
65. Mullick J., Singh A.K., Panse Y., Yadav V., Bernet J., and Sahu A. Identification of functional domains in kaposica, the complement control protein homolog of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8). J. Virol. 79 (2005) 5850-5856
66. Naranatt P.P., Akula S.M., Zien C.A., Krishnan H.H., and Chandran B. Kaposi's sarcoma-associated herpesvirus induces the phosphatidylinositol 3-kinase-PKC-zeta-MEK-ERK signaling pathway in target cells early during infection: implications for infectivity. J. Virol. 77 (2003) 1524-1539
67. Norman D.G., Barlow P.N., Baron M., Day A.J., Sim R.B., and Campbell I.D. Three-dimensional structure of a complement control protein module in solution. J. Mol. Biol. 219 (1991) 717-725
68. Oppermann M., Manuelian T., Jozsi M., Brandt E., Jokiranta T.S., Heinen S., Meri S., Skerka C., Gotze O., and Zipfel P.F. The C-terminus of complement regulator Factor H mediates target recognition: evidence for a compact conformation of the native protein. Clin. Exp. Immunol. 144 (2006) 342-352
69. Ormsby R.J., Jokiranta T.S., Duthy T.G., Griggs K.M., Sadlon T.A., Giannakis E., and Gordon D.L. Localization of the third heparin-binding site in the human complement regulator factor H1. Mol. Immunol. 43 (2006) 1624-1632
70. Pangburn M.K. Cutting edge: localization of the host recognition functions of complement factor H at the carboxyl-terminal: implications for hemolytic uremic syndrome. J. Immunol. 169 (2002) 4702-4706
71. Pangburn M.K., Atkinson M.A., and Meri S. Localization of the heparin-binding site on complement factor H. J. Biol. Chem. 266 (1991) 16847-16853
72. Prodinger W.M., Hellwage J., Spruth M., Dierich M.P., and Zipfel P.F. The C-terminus of factor H: monoclonal antibodies inhibit heparin binding and identify epitopes common to factor H and factor H-related proteins. Biochem. J. 331 Pt 1 (1998) 41-47
73. Ram S., Sharma A.K., Simpson S.D., Gulati S., McQuillen D.P., Pangburn M.K., and Rice P.A. A novel sialic acid binding site on factor H mediates serum resistance of sialylated Neisseria gonorrhoeae. J. Exp. Med. 187 (1998) 743-752
74. Rickinson A. Concluding overview: looking back, looking forward. Philos. Trans. R. Soc. Lond. B. Biol. Sci. 356 (2001) 595-604
75. Rosengard A.M., Alonso L.C., Korb L.C., Baldwin III W.M., Sanfilippo F., Turka L.A., and Ahearn J.M. Functional characterization of soluble and membrane-bound forms of vaccinia virus complement control protein (VCP). Mol. Immunol. 36 (1999) 685-697
76. Rosengard A.M., Liu Y., Nie Z., and Jimenez R. Variola virus immune evasion design: expression of a highly efficient inhibitor of human complement. Proc. Natl. Acad. Sci. U.S.A. 99 (2002) 8808-8813
77. Russo J.J., Bohenzky R.A., Chien M.C., Chen J., Yan M., Maddalena D., Parry J.P., Peruzzi D., Edelman I.S., Chang Y., and Moore P.S. Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8). Proc. Natl. Acad. Sci. U.S.A. 93 (1996) 14862-14867
78. Sahu A., Isaacs S.N., Soulika A.M., and Lambris J.D. Interaction of vaccinia virus complement control protein with human complement proteins: factor I-mediated degradation of C3b to iC3b1 inactivates the alternative complement pathway. J. Immunol. 160 (1998) 5596-5604
79. Schulz T.F. The pleiotropic effects of Kaposi's sarcoma herpesvirus. J. Pathol. 208 (2006) 187-198
80. Searles R.P., Bergquam E.P., Axthelm M.K., and Wong S.W. Sequence and genomic analysis of a Rhesus macaque rhadinovirus with similarity to Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8. J. Virol. 73 (1999) 3040-3053
81. Sfyroera G., Katragadda M., Morikis D., Isaacs S.N., and Lambris J.D. Electrostatic modeling predicts the activities of orthopoxvirus complement control proteins. J. Immunol. 174 (2005) 2143-2151
82. Sharma A.K., and Pangburn M.K. Identification of three physically and functionally distinct binding sites for C3b in human complement factor H by deletion mutagenesis. Proc. Natl. Acad. Sci. U.S.A. 93 (1996) 10996-11001
83. Shukla D., and Spear P.G. Herpesviruses and heparan sulfate: an intimate relationship in aid of viral entry. J. Clin. Invest. 108 (2001) 503-510
84. Smith R.A. Targeting anticomplement agents. Biochem. Soc. Trans. 30 (2002) 1037-1041
85. Smith S.A., Mullin N.P., Parkinson J., Shchelkunov S.N., Totmenin A.V., Loparev V.N., Srisatjaluk R., Reynolds D.N., Keeling K.L., Justus D.E., Barlow P.N., and Kotwal G.J. Conserved surface-exposed K/R-X-K/R motifs and net positive charge on poxvirus complement control proteins serve as putative heparin binding sites and contribute to inhibition of molecular interactions with human endothelial cells: a novel mechanism for evasion of host defense. J. Virol. 74 (2000) 5659-5666
86. Smith S.A., Sreenivasan R., Krishnasamy G., Judge K.W., Murthy K.H., Arjunwadkar S.J., Pugh D.R., and Kotwal G.J. Mapping of regions within the vaccinia virus complement control protein involved in dose-dependent binding to key complement components and heparin using surface plasmon resonance. Biochim. Biophys. Acta 1650 (2003) 30-39
87. Soulier J., Grollet L., Oksenhendler E., Cacoub P., Cazals-Hatem D., Babinet P., d'Agay M.F., Clauvel J.P., Raphael M., and Degos L. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease. Blood 86 (1995) 1276-1280
88. Spear P.G., and Longnecker R. Herpesvirus entry: an update. J. Virol. 77 (2003) 10179-10185
89. Spear G.T., Lurain N.S., Parker C.J., Ghassemi M., Payne G.H., and Saifuddin M. Host cell-derived complement control proteins CD55 and CD59 are incorporated into the virions of two unrelated enveloped viruses. Human T cell leukemia/lymphoma virus type I (HTLV-I) and human cytomegalovirus (HCMV). J. Immunol. 155 (1995) 4376-4381
90. Spiller O.B., Blackbourn D.J., Mark L., Proctor D., and Blom A.M. Functional activity of the complement regulator encoded by Kaposi's sarcoma-associated herpesvirus. J. Biol. Chem. 278 (2003) 9283-9289
91. Spiller O.B., Mark L., Blue C.E., Proctor D.G., Aitken J.A., Blom A.M., and Blackbourn D.J. Dissecting the regions of virion-associated Kaposi's sarcoma-associated herpesvirus complement control protein required for complement regulation and cell binding. J. Virol. 80 (2006) 4068-4078
92. Spiller O.B., Morgan B.P., Tufaro F., and Devine D.V. Altered expression of host-encoded complement regulators on human cytomegalovirus-infected cells. Eur. J. Immunol. 26 (1996) 1532-1538
93. Spiller O.B., Robinson M., O'Donnell E., Milligan S., Morgan B.P., Davison A.J., and Blackbourn D.J. Complement regulation by Kaposi's sarcoma-associated herpesvirus ORF4 protein. J. Virol. 77 (2003) 592-599
94. Stoiber H., Pruenster M., Ammann C.G., and Dierich M.P. Complement-opsonized HIV: the free rider on its way to infection. Mol. Immunol. 42 (2005) 153-160
95. Sunil-Chandra N.P., Efstathiou S., Arno J., and Nash A.A. Virological and pathological features of mice infected with murine gamma-herpesvirus 68. J. Gen. Virol. 73 Pt 9 (1992) 2347-2356
96. Vanderplasschen A., Mathew E., Hollinshead M., Sim R.B., and Smith G.L. Extracellular enveloped vaccinia virus is resistant to complement because of incorporation of host complement control proteins into its envelope. Proc. Natl. Acad. Sci. U.S.A. 95 (1998) 7544-7549
97. Villoutreix B.O., Hardig Y., Wallqvist A., Covell D.G., Garcia de Frutos P., and Dahlback B. Structural investigation of C4b-binding protein by molecular modeling: localization of putative binding sites. Proteins 31 (1998) 391-405
98. Walport M.J. Complement. First of two parts. N. Engl. J. Med. 344 (2001) 1058-1066
99. Wang F.Z., Akula S.M., Pramod N.P., Zeng L., and Chandran B. Human herpesvirus 8 envelope glycoprotein K8.1A interaction with the target cells involves heparan sulfate. J. Virol. 75 (2001) 7517-7527
100. Wong S.W., Bergquam E.P., Swanson R.M., Lee F.W., Shiigi S.M., Avery N.A., Fanton J.W., and Axthelm M.K. Induction of B cell hyperplasia in simian immunodeficiency virus-infected rhesus macaques with the simian homologue of Kaposi's sarcoma-associated herpesvirus. J. Exp. Med. 190 (1999) 827-840
101. Zhu F.X., Chong J.M., Wu L., and Yuan Y. Virion proteins of Kaposi's sarcoma-associated herpesvirus. J. Virol. 79 (2005) 800-811
102. Zipfel P.F., Heinen S., Jozsi M., and Skerka C. Complement and diseases: defective alternative pathway control results in kidney and eye diseases. Mol. Immunol. 43 (2006) 97-106
103. Zipfel P.F., Skerka C., Hellwage J., Jokiranta S.T., Meri S., Brade V., Kraiczy P., Noris M., and Remuzzi G. Factor H family proteins: on complement, microbes and human diseases. Biochem. Soc. Trans. 30 (2002) 971-978